(ASAPF) – Company Press Releases
-
AURORA SPINE ANNOUNCES ATTENDANCE AT NORTH AMERICAN NEUROMODULATION SOCIETY (NANS) ANNUAL MEETING
-
Aurora Spine Corporation Announces Newly Published Paper on First 6-month Clinical Evaluation of its ZIP™ Fusion Implant
-
Aurora Spine Grants Stock Options
-
Aurora Spine Corporation Schedules Conference Call to Update Investors and Discuss Third Quarter Fiscal Year 2023 Financial Results
-
Aurora Spine Corporation Schedules Release of First Quarter Fiscal Year 2023 Financial Results and Conference Call
-
Aurora Spine Corporation Schedules Release of Fourth Quarter and Fiscal Year 2022 Financial Results and Conference Call
-
Aurora Spine to Present at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023 & 1x1 Meetings on Thursday, April 27, 2023
-
Aurora Spine to Attend the American Association of Neurological Surgeons Annual Meeting
-
Aurora Spine Announces Initial Surgeries Conducted Using its SiLO TFX™ MIS Sacroiliac Joint Fixation System
-
Aurora Spine Announces Presentation on DEXA Technology at the American Association of Neurological Surgeons Annual Meeting
-
Aurora Spine Receives IRB Multi-Site Selection Approval for its DEXA-C™ Cervical Interbody System
-
Aurora Spine Receives IRB Approval To Commence Multicenter Study for its DEXA-C™ Cervical Interbody System
-
Aurora Spine to Present at the Planet MicroCap Showcase: VIRTUAL 2022 on Wednesday, December 7, 2022
-
Aurora Spine Corporation Schedules Release of Third Quarter Fiscal Year 2022 Financial Results and Conference Call
-
Aurora Spine Corporation Announces Positive Interim Results from Clinical Study using ZIP™ MIS Interspinous Fusion System
-
Aurora Spine Corporation to Attend the North American Spine Society (NASS) Annual Meeting
-
Aurora Spine Receives 2022 Best New Spine Technology Award for its DEXA bone density-matched spine implant innovation
-
Aurora Spine Corporation Announces FDA 510(k) Clearance for its SiLO TFX™ MIS Sacroiliac Joint Fixation System
-
Aurora Spine Corporation Announces FDA 510(k) Clearance for its SiLO TFX™ MIS Sacroiliac Joint Fixation System
-
Aurora Spine Corporation to Participate in the Lytham Partners Fall 2022 Investor Conference
-
Aurora Spine Corporation Announces Record Second Quarter Fiscal 2022 Financial Results
-
Aurora Spine Corporation Schedules Release of Second Quarter Fiscal Year 2022 Financial Results and Conference Call
-
Aurora Spine Announces New FDA indication clearance of Lumbar Spinal Stenosis for its ZIP™ series of MIS implants
-
Aurora Spine Corporation Issued Patent by USPTO For Its Interlaminar Single Implant Technology For Motion Preservation or Fusion
-
Aurora Spine Corporation Receives FDA 510(k) Clearance for DEXA SOLO-LTM Anterior Lumbar Interbody Fusion Device as part of its DEXA Technology Platform
-
Aurora Spine Corporation Schedules Release for First Quarter Fiscal Year 2022 Financial Results and Conference Call
-
Aurora Spine Corporation Schedules Release for Fourth Quarter and Fiscal Year 2021 Financial Results and Conference Call
-
Aurora Spine Corporation to Participate in the Lytham Partners Spring 2022 Investor Conference
-
Aurora Spine Corporation Announces Initial Implantation of the World’s First Bone Density Matched DEXA-C Cervical Interbody Fusion Device
-
Aurora Spine Corporation Announces Co-Marketing Agreement for its DEXA Platform with Echolight Medical
-
Aurora Spine Corporation Announces Preliminary Revenue for Fourth Quarter and Fiscal 2021
-
Aurora Spine Receives “Notice of Allowance” for Patent for Spinal Implant for Motion Preservation or Fusion
-
Aurora Spine Announces Initial Surgeries Using its Proprietary APOLLOTM Cervical Plate
-
Aurora Spine Corporation Announces Newly Published Paper on Need for a Bone Mineral Density-Matched Interbody Cage
-
Aurora Spine Corporation to Participate in the Lytham Partners Winter 2021 Investor Conference
-
Aurora Spine Corporation Retains PRIA Healthcare to Improve Patient Access to Proprietary Products
-
Aurora Spine Corporation to Present at the Lytham Partners Fall 2021 Investor Conference
-
Aurora Spine Corporation Announces Participation at the North American Spine Society Annual Meeting
-
Aurora Spine Corporation Announces Closing of C$6.5 Million Private Placement with Institutional Investors
-
Aurora Spine Corporation Announces C$6.5 Million Private Placement with Institutional Investors
-
Aurora Spine Corporation Announces First Patients in Multicenter Study of ZIP® Interspinous Fixation Device
-
Aurora Spine Corporation Announces FDA 510(k) Clearance for DEXA-C™ Cervical Interbody System
-
Aurora Spine Corporation to Participate in Alliance Global Partners Virtual MedTech Summer Conference
-
Aurora Spine Corporation to Attend Third Annual American Society of Pain & Neuroscience Conference
-
Aurora Spine Corporation to Present at the Lytham Partners Summer 2021 Investor Conference
-
Aurora Spine receives IRB approval to commence registration for Multicenter Study of its SiLO™ Device for SI Joint Pain
-
Aurora Spine receives IRB approval for Multicenter Study of its ZIP® Interspinous Fixation Device for Relief of Back Pain
-
Aurora Spine Receives FDA 510(K) Clearance for Its Proprietary APOLLO Anterior Cervical Plate
-
Aurora Spine to Present at Lytham Partners Spring 2021 Investor Conference
-
Aurora Spine Corporation Announces Successful Launch of its Proprietary SiLO™ Posterior SI Joint Fusion System
Back to ASAPF Stock Lookup
